NOVARIS EQUITY
NOVARIS EQUITY is a french venture capital firm composed of more than 46 Business Angels with the main mission to invest money in french startups. The company has been officially incorporated in June 2008 but still open to projects and investors until June 2011. Jump to http://www.novaris.fr
NOVARIS EQUITY
Founded:
2008-05-01
Status:
Closed
Email Addresses:
[email protected]
Technology used in webpage:
SPF
Similar Organizations
Studio legale Tedioli
Italian business law firm
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2009-10-12 | Qweeby | NOVARIS EQUITY investment in Angel Round - Qweeby | N/A |
More informations about "NOVARIS EQUITY"
Equity - Novartis
As an organization, we actively promote Lesbian, Gay, Bi, Transgender, Queer & Intersex (LGBTQI+) equity and awareness at work and in our wider society, in partnership with our …See details»
Diversity, equity and inclusion - Novartis
At Novartis, we’re striving to build an inclusive and equitable workplace that empowers all our people to achieve their full potential. We seek to educate our people on inclusivity and provide all associates with equal opportunities to …See details»
The Novartis Health Equity Initiative
The Novartis Health Equity Initiative is a $500,000 CAD fund created to help tackle persistent health disparities and promote equal access to healthcare in Canada. The initiative focuses …See details»
Novartis Canada launches $500,000 funding initiative …
Jul 8, 2024 · In this open call for ideas, Novartis will award $500,000 CAD to non-profit projects focused on improving health equity in three pivotal areas: social/cultural inclusivity of care, health...See details»
Novartis Canada launches $500,000 funding initiative to improve …
Jul 8, 2024 · Novartis Pharmaceuticals Canada Inc. (Novartis) today announced the launch of a new health equity initiative, aimed at addressing health disparities and promoting equitable …See details»
Novartis: Breaking Barriers for Health Equity
In a world where disparities in healthcare access persist, Novartis is working with partners to achieve global health equity. Swiss pharmaceutical company Novartis envisions a world where...See details»
Novartis inks 10-year pledge to improve equity in health
Jul 20, 2021 · Novartis and the Novartis US Foundation have announced a decade-long pledge to work with more than two dozen historically black colleges, universities, medical schools, and other institutions to address root causes of …See details»
Novartis Foundation
The Novartis Foundation focuses on the world’s most pressing health challenges: cardiovascular disease and health inequity. We take a population health approach, which means widening the lens from a narrow focus on healthcare …See details»
Novartis announces new organizational structure to accelerate …
Apr 4, 2022 · Novartis will integrate the Pharmaceuticals and Oncology business units and create two separate commercial organizations with a stronger geographic focus—Innovative …See details»
NOVARIS EQUITY - Crunchbase Investor Profile & Investments
NOVARIS EQUITY is a french venture capital firm composed of more than 46 Business Angels with the main mission to invest money in french startups. The company has been officially …See details»
NOVN.S - | Stock Price & Latest News | Reuters
4 days ago · 2.65 mean rating - 23 analysts. Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active...See details»
Global health - Novartis
Today, we apply our expertise and full organizational capability to address major, unresolved global health challenges. We prioritize the needs of patients, their families and communities, …See details»
Novartis accelerates efforts toward ESG targets to increase
Basel, September 30, 2021 — At its eighth annual ESG investor event hosted today, Novartis shared progress against its Environmental, Social and Governance (ESG) targets and updated …See details»
Novartis accelerates efforts toward ESG targets to increase access …
Basel, September 30, 2021 — At its eighth annual ESG investor event hosted today, Novartis shared progress against its Environmental, Social and Governance (ESG) targets and updated …See details»
Director, ESG & License to Operate Policy | Novartis
1 day ago · Key Responsibilities:Drive ESG policy shaping, focusing on governance, green chemistry and “license to operate” topics incl. health and environment in key geographies in …See details»
Share ownership - Novartis
As of December 31, 2023, Novartis AG had approximately 183 000 registered shareholders. Registered shares held by nominees are shown in the country where the company/affiliate …See details»
Investors - Novartis
Oct 29, 2024 · Learn how Novartis uses science-based innovation to create value over the longer term for our company, our shareholders, and society.See details»
Grants and Donations | Novartis Canada
Starting in January 2022, all grant and donation applicants will need to meet at least one of the new three guiding principles: Innovative digital and data initiatives that strengthen sustainable …See details»
Novartis ranks first in 2024 Access to Medicine Index
Nov 19, 2024 · Novartis has risen three places to secure the top spot on the 2024 Access to Medicine Index; Basel, November 19, 2024 – Novartis has ranked first in the 2024 Access to …See details»
Director, NPS Design, Insights and Intelligence -Remote - Novartis
Nov 19, 2024 · Socialize and train a group of design champions from across the NPS organizationStandardize pull through with disease state and center of excellence stakeholders, …See details»